10x Genomics, Inc. Revenues
10x Genomics, Inc. (TXG) reported Revenues of $71.91 million for the 3-month period ending 2020-03-31, per its 10-Q filed 2020-05-12.
Discontinued › Income Statement
us-gaap:Revenues · last filed 2020-05-12
- 10x Genomics, Inc. revenues for the quarter ending 2020-03-31 was $71.91M, a 34.21% increase year-over-year.
- 10x Genomics, Inc. revenues for the quarter ending 2019-12-31 was $75.29M, a 48.93% increase year-over-year.
- 10x Genomics, Inc. revenues for the quarter ending 2019-09-30 was $61.21M, a 67.20% increase year-over-year.
- 10x Genomics, Inc. revenues for the quarter ending 2019-06-30 was $55.82M, a 75.84% increase year-over-year.
- 10x Genomics, Inc. revenues for fiscal 2019 was $245.89M, a 68.06% increase from fiscal 2018.
- 10x Genomics, Inc. revenues for fiscal 2018 was $146.31M, a 105.83% increase from fiscal 2017.
- 10x Genomics, Inc. revenues for fiscal 2017 was $71.08M.
| Period end | Revenues 3 month | Revenues 6 month | Revenues 9 month | Revenues 12 month |
|---|---|---|---|---|
| 2020-03-31 | $71.91M 10-Q · filed 2020-05-12 | $147.19M derived: sum of 2 quarters · filed 2020-05-12 | $208.40M derived: sum of 3 quarters · filed 2020-05-12 | $264.22M derived: sum of 4 quarters · filed 2020-05-12 |
| 2019-12-31 | $75.29M 10-K · filed 2020-02-27 | $136.50M derived: sum of 2 quarters · filed 2020-02-27 | $192.31M derived: sum of 3 quarters · filed 2020-02-27 | $245.89M 10-K · filed 2020-02-27 |
| 2019-09-30 | $61.21M 10-K · filed 2020-02-27 | $117.03M derived: sum of 2 quarters · filed 2020-02-27 | $170.60M 10-Q · filed 2019-11-12 | $221.16M derived: sum of 4 quarters · filed 2020-05-12 |
| 2019-06-30 | $55.82M 10-K · filed 2020-02-27 | $109.40M derived: sum of 2 quarters · filed 2020-05-12 | $159.95M derived: sum of 3 quarters · filed 2020-05-12 | $196.56M derived: sum of 4 quarters · filed 2020-05-12 |
| 2019-03-31 | $53.58M 10-Q · filed 2020-05-12 | $104.13M derived: sum of 2 quarters · filed 2020-05-12 | $140.74M derived: sum of 3 quarters · filed 2020-05-12 | $172.48M derived: sum of 4 quarters · filed 2020-05-12 |
| 2018-12-31 | $50.55M 10-K · filed 2020-02-27 | $87.16M derived: sum of 2 quarters · filed 2020-02-27 | $118.91M derived: sum of 3 quarters · filed 2020-02-27 | $146.31M 10-K · filed 2020-02-27 |
| 2018-09-30 | $36.61M 10-K · filed 2020-02-27 | $68.35M derived: sum of 2 quarters · filed 2020-02-27 | $95.76M 10-Q · filed 2019-11-12 | |
| 2018-06-30 | $31.74M 10-K · filed 2020-02-27 | $59.15M derived: sum of 2 quarters · filed 2020-02-27 | ||
| 2018-03-31 | $27.41M 10-K · filed 2020-02-27 | |||
| 2017-12-31 | $71.08M 10-K · filed 2020-02-27 |